Listener Training for Improved Intelligibility of People With Parkinson's Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Stephanie Borrie, PhD
- Phone Number: 435-797-1388
- Email: stephanie.borrie@usu.edu
Study Contact Backup
- Name: Morgan Robertson, PhD
- Phone Number: 435-797-1388
- Email: morgan.robertson@usu.edu
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Recruiting
- Florida State University
-
Contact:
- Kaitlin Lansford, PhD
- Phone Number: 850-644-8443
- Email: klansford@fsu.edu
-
Principal Investigator:
- Kaitlin Lansford, PhD
-
-
Utah
-
Logan, Utah, United States, 43221
- Recruiting
- Utah State University
-
Contact:
- Stephanie Borrie, PhD
- Phone Number: 435-797-1388
- Email: stephanie.borrie@usu.edu
-
Principal Investigator:
- Stephanie Borrie, PhD
-
Sub-Investigator:
- Sarah Leopold, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary language is English
- 18 years or older
- medical diagnosis of Parkinson's disease (patient participants)
- speech diagnosis of hyperkinetic dysarthria, exhibiting hallmark characteristics (patient participants)
Exclusion Criteria:
- Severe cognitive impairment
- Less than 18 years of age
- Primary language other than English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental Condition
Listener receives speech of patient with dysarthria
|
Partner participants are presented with individual audio phrases that make up passage reading speech stimuli and orthographic transcriptions of what the patient is saying.
Partners are asked to listen carefully to the audio files and use the written subtitles to help them understand what is being said.
|
|
Sham Comparator: Control condition
Listener receives speech of speaker with no speech disorder
|
Partner participants are presented with individual audio phrases that make up passage reading speech stimuli and orthographic transcriptions of what the patient is saying.
Partners are asked to listen carefully to the audio files and use the written subtitles to help them understand what is being said.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speech intelligibility
Time Frame: pretest, during training, immediate posttest, one week posttest, one month posttest
|
Percent words correct (PWC)
|
pretest, during training, immediate posttest, one week posttest, one month posttest
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Communicative Participation Item Bank
Time Frame: Pretest, one month posttest
|
Patient and partner reported summed score across different communication situations
|
Pretest, one month posttest
|
|
Listening effort
Time Frame: Pretest, one week posttest, one month posttest
|
Rating scale, 0-100 scale with question "how easy is this speech to understand", with endpoints of 'difficult' on the zero side and 'easy' on the 100 side
|
Pretest, one week posttest, one month posttest
|
|
Comprehension
Time Frame: Pretest, one week posttest, one month posttest
|
Story comprehension accuracy score, listeners answer a series of multiple choice comprehension questions, accuracy is defined as how many correct responses they choose for each story
|
Pretest, one week posttest, one month posttest
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Stephanie Borrie, PhD, Utah State University
- Principal Investigator: Kaitlin Lansford, PhD, Florida State University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 14004 (City of Hope Medical Center)
- 1R01DC020930 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.